ADOCIA Announces the Expiration of Exclusive Right to Negotiate Partnership for M1Pram with SANOFI

PartnershipnegativeM1PramNegative

AI Analysis

Summary

ADOCIA announced the expiration of its exclusive right to negotiate a partnership with Sanofi for the drug M1Pram. The termination of exclusive negotiation rights represents a setback for the potential collaboration between the two companies.

Outcome Details

Exclusive right to negotiate partnership expired

Importance:5/10

Sentiment:

-0.70

partnership_terminationexclusive_negotiation_rightsM1Pramcollaboration_ended

Related Companies

$ADOC.PA $SNY

Read the original article

Published by yahoo_finance on July 3, 2026 4:00 PM

Read Original